Virometix ^Company

Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs to prevent and treat infectious and chronic human diseases. They use rational molecular design, chemical synthesis, and their Synthetic Virus-Like Particle platform technology to produce vaccine candidates with superior safety, efficacy, and stability properties. Their focus is on addressing the growing demands and health threats from complex viral and bacterial pathogens in an increasingly global world.